Elementis Reports Strong H1 Revenue and Profit Growth Amid Strategic Advancements
Elementis (LON:ELM) reported higher first-half revenue, profit, and margins in fiscal year 2026 as it continued to execute its Elevate Elementis strategy. CEO Luc van Ravenstein highlighted a 5% increase in organic constant-currency revenue alongside a 16% rise in profit and adjusted operating margins reaching 23%. CFO Kath Kearney-Croft noted reported group revenue rose by 9.4% year-over-year to $318.2 million, driven partly by favorable foreign exchange effects and the acquisition of skincare business Alchemy. The company also completed the sale of its pharmaceutical manufacturing unit in June and initiated a share buyback program. Revenue growth was led by coatings demand in Asia and EMEA but offset somewhat by weaker performance in North America due to soft construction activity. Adjusted operating profit increased 16.4% year-over-year, with margin improvement attributed to volume gains and cost management. Segment-wise, personal care revenue rose organically while Alchemy's integration is on track for double-digit growth. Coatings saw strong regional expansion despite North American challenges.
Tickers: $ELM
Topics: chemicals profitability revenue growth specialty chemicals strategy update